- Gao M, Song Y, Liang J, Chen T, Luo J, Du P, Wang H, Leng H, Wang Z*, Ma X*, Wang K*, Zhao Y*, 2025. Sensitizing ferroptotic and apoptotic cancer therapy via tailored micelles-mediated coenzyme and ATP depletion under hypoxia. J Control Release, 381:113572.
- Tian S, Zhou S, Wu W, Lin Y, Wang T, Sun H, Aniwan A, Li Y, Wang C, Li X, Yu P*, Zhao Y*, 2025. GLP-1 receptor agonists alleviate diabetic kidney injury via β-klotho-mediated ferroptosis inhibition. Adv Sci, 12(4): 2409781.
- Luo J, Shang Y, Zhao N, Lv X, Wang Z, Li X*, Meng X*, Zhao Y*, 2025. Hypoxia-responsive micelles deprive cofactor of stearoyl-coA desaturase-1 and sensitize ferroptotic ovarian cancer therapy. Biomaterials, 314, 122820.
- Liu F, Li Y, Li Y, Wang Z, Li X*, Liu Y*, Zhao Y*, 2025. Triggering multiple modalities of cell death via dual-responsive nanomedicines to address the narrow therapeutic window of β-lapachone. J Colloid Interface Sci, 678, 915-924.
- Hou S, Li Y, Chen Q, Yang J*, Zhao P*, Zhao Y*, 2024. Mechano-triggered eradication of dentinal tubule biofilm via in situ generation of nanoscale sonosensitizer by the tailored irrigation formulation. Int J Pharm, 665, 124655.
- Li M, Dong Y, Wang Z, Zhao Y*, Dai Y*, Zhang B*, 2024. Engineering hypoxia-responsive 6-aminonicotinamide prodrugs for on-demand NADPH depletion and redox manipulation. J Mater Chem B, 12(33), 8067-8075.
- Tian S, Yang X, Lin Y, Li X, Zhou S, Yu P*, Zhao Y*, 2024. PDK4-mediated Nrf2 inactivation contributes to oxidative stress and diabetic kidney. Cell Signal, 121: 111282.
- Li Y, Zhai W, Wang Z, Petrov AM, Zhang B*, Zhao Y*, 2024. Ultrasound-aided cellular uptake and endosomal escape of nanoparticles via the membrane surface redox reaction. Chem Res Chin Uni, in press (doi: 10.7503/cjcu20240265).
- Fan L, Du P, Li Y, Chen X, Liu F, Liu Y, Petrov AM, Li X*, Wang Z*, Zhao Y*, 2024. Targeted liposomes sensitize plastic melanoma to ferroptosis via senescence induction and coenzyme depletion. ACS Nano, 18(9): 7011-7023.
- Song Y, Xu X, Wang Z*, Zhao Y*, 2024. Metal-organic framework-based nanomedicines for ferroptotic cancer therapy. Adv Healthc Mater, 13(11): e2303533.